CLUB DRUGS: EMERGING TRENDS AND RISKS Open Road ‘Legal Highs – Clubbing Drugs’ Conference Wednesday 23 rd January 2013 Rick Andrews National Treatment.

Slides:



Advertisements
Similar presentations
NDTMS data on club drugs and NPS
Advertisements

M. Fe Caces, Ph. D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC June 2003 Treatment.
Drug-related deaths and treatment We hold an extract of data from the ONS drug poisoning database which contains all drug poisonings registered between.
Injecting and BBVs – NDTMS and prevalence data Current prevalence data for injecting among opiate/crack users (2010/11) shows continuation of a steady.
London, Drugs and You – the Role of Elected Members May 11th 2009 Facilitated by David MacKintosh and Sara McGrail.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Differences in Characteristics of Heroin Inhalers and Injectors at Admission to Treatment J. C. Maxwell, R. T. Spence, & T. M. Bohman UT Center for Social.
American Dental Education Association Immediate Practice Plans of U.S. Dental School Graduates, 1980 – 2006 (of those entering private practice upon graduation)
Welfare to Careers Medger Evers College Metropolitan College of New York Pace University December 2, 2008.
An investigation of substance use patterns and associated issues in urban treatment-seeking Northern Plains American Indians Native Research Network 2011.
Mansell 2 Services for people with learning disabilities whose behaviour presents a challenge Jim Mansell.
Role The NHS new treatment landscape Annette Dale-Perera Strategic Director of Addictions and Offender Care CNWL NHS Foundation Trust.
Results from the 2006 National Survey on Drug Use and Health (NSDUH) Briefing for DHHS, September 5, 2007 Joe Gfroerer Office of Applied Studies Substance.
Vermilion County Action Team Laurie Krolikowski & Susan Werner.
Drug Trends in Washington State & King County Caleb J. Banta-Green MPH MSW Alcohol & Drug Abuse Institute University of Washington
International Labour Organization Policy Brief on Employment and Social Protection Indicators Christina Behrendt (Social Protection Sector) Mariàngels.
The Dual Crisis: HIV and Human Rights: Journalism’s Role in the Fight Against Stigma and Discrimination Richard Burzynski, UNAIDS 20 th International AIDS.
ARQ part II data management Training pack 1: Content and conceptual issues.
Indicators of health and disease frequency measures
Major findings from the 2013 World Drug Report. Drug use Overall drug use, including problem drug use, has remained largely stable over the past 5 years.
The 2012/13 reforms of part-time higher education funding in England Claire Callender Professor of Higher Education Birkbeck and Institute of Education.
Rosanna O’Connor Director of Delivery National Treatment Agency.
Carlos Navarro-Colorado SC-UK, ENN Hanoi, Supported by: OFDA, CDI Current practice in the treatment of Moderate Malnutrition in emergencies. Reflections.
Beyond Condoms COMMERCIAL MARKET STRATEGIES NEW DIRECTIONS IN REPRODUCTIVE HEALTH Should social marketing programs do more to promote abstinence and partner.
Implementing NICE guidance
Sponsored by Eastman Kodak Company Mayor William A. Johnson, Jr. & Police Chief Robert J. Duffy.
A Conceptual Framework for Co- Occurring Disorders within a Behavioral Health Care System Reference: National Dialogue on Co-occurring Mental Health and.
Annual Conference May 19 – 22, 2015 St. Augustine, FL.
Recreational Drug Use In Medway Several controlled substances are currently widely used in Medway: –Cocaine (powder) –‘Skunk’ cannabis –Heroin (powder)
NATMS Overview Kevin Shelton Treatment Information Manager 2 June 2009.
Recent trends and economic impact of emigration from Latvia OECD/MFA Conference Riga, December 17, 2012 Mihails Hazans University of Latvia Institute for.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
The Human Population Chapter 9. Studying Human Population  Need Slides.
MRCPsych seminar series Epidemiology of addictive disorders: a brief review Dr Stuart McLaren March 2010.
All Change! Infections, injecting drug use and harm reduction. Vivian Hope IDU Team, HIV & STI Department, Health Protection Services – Colindale Dr Vivian.
Outcomes of Treatment for Methamphetamine Use: LA County (“Treatment-as-Usual”) M.-L. Brecht UCLA Integrated Substance Abuse Programs CATES 3/30/2004.
Drug Prices in Canada and the US: More Than Meets the Eye? National Academy of Social Insurance Annual Conference Wayne Critchley Executive Director, PMPRB.
Dundee Partnership Community Conference 17 th September 2011 What are we trying to achieve? The national picture Dr Brian Kidd – NHS Tayside.
EXTENDING THE THERAPEUTIC JUSTICE MODEL TO PROBLEM GAMBLERS Mark G. Farrell, JD; Jessica Aungst Weitzel, MPH; Thomas H. Nochajski, PhD, Buffalo Center.
Delivering independent intelligence for health and wellbeing Session 3: NDTMS Core data set G ADULT SERVICES Part 2: All Other Changes Jill Smith Public.
Nursing in the Ever- Evolving Health Care System.
Drug Abuse Trends in the State of California Presented to: CA Association for Criminal Justice Research March 17, 2005 Presented by: Kiku Annon, MA, WestEd.
The Sexual Practices of Inhalant Nitrate & Methamphetamine Users Perry N. Halkitis, M.S., Ph.D. Michael T. Maurer, Ph.D., M.H.A. New York University Presented.
1 Essential NDTMS Core Data Set G Training 17 th March 2010 John Liddell, Deputy Regional Manager.
Epidemiology of addictive disorders: a brief review MRCPsych addiction psychiatry seminar series Dr Stuart McLaren 2 nd March 2012.
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
Drug Misuse Monitoring Identifying Trends Predicting Future Demands Responding to Public Health Needs J McVeigh, MA Bellis & R Thomson.
3.14 X AXIS 6.65 BASE MARGIN 5.95 TOP MARGIN 4.52 CHART TOP LEFT MARGIN RIGHT MARGIN ©TNS 2013 Are ‘better’ interviewers more successful at.
#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.
Jennifer R. Havens, PhD, MPH Associate Professor
… But, What About Tomorrow? Tom Stinson, State Economist Tom Gillaspy, State Demographer January
DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration OFFICE OF APPLIED STUDIES Treatment Episode Data Set.
Citywide Drugs Crisis Campaign 20 years experience of Community Involvement – Key Lessons for the next National Drugs Strategy 12 TH NOVEMBER 2015.
TM Substance Use Transitions from Initial Use to Regular Use to Discontinuance Ralph S. Caraballo, Ph.D., MPH Office on Smoking and Health, CDC, Atlanta.
Differences in drug use by ethnicity: Do they suggest inequity in access to drug treatment? March 2005 Peter Madden Senior Analyst, Matthew Hickman Senior.
Annual report 2012: the state of the drugs problem in Europe Name, date.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Recidivism Rates for DCJ Offenders Exiting Residential Treatment June 2007 Kim Pascual Research & Evaluation.
Accutane ® Use and Epidemiology John E. La Flore, MD, MSPH Vice President, Drug Safety & Risk Management Hoffmann-La Roche Inc.
 Reliant on robust monitoring systems  Emphasis changed over time  Limited by data collection systems available  Data collection adapts to allow wider.
Drug Proliferation in Bulgaria Center for the Study of Democracy June 2007.
Substance Misuse in LGBT populations
Drug addiction: Therapeutic problems in everyday clinical practice
The Efficacy of RN Supervised Safe Injection Sites
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Registration of treatment demands for substance use disorders in Belgium : Why are some clients registered anonymously? Jérôme Antoine, Françoise Renard.
Drugs the law & government responses
Risk Reduction on New Drugs,
Presentation transcript:

CLUB DRUGS: EMERGING TRENDS AND RISKS Open Road ‘Legal Highs – Clubbing Drugs’ Conference Wednesday 23 rd January 2013 Rick Andrews National Treatment Agency Slide 1

2 CLUB DRUGS: EMERGING TRENDS AND RISKS  First analysis of treatment data relating to these substances  Based upon NDTMS data since  ‘Club drugs’ – a collective term often used generically to describe a increasingly wide range of substances  High numbers of reported users, relatively small numbers presenting to treatment Slide 2

Context:  BCS indicates that overall drug use is declining from 3.3m in 2005 to 2.9m in 2011  Overall numbers in treatment declining year on year  Same period use of club drugs has risen.  In estimated 1m club drug users  Made up 4% of all new entrants to drug treatment in 2011/12  Ketamine use in general population remained constant – but increasing nos. presenting to treatment  Numbers presenting to treatment increased by 50%  Make up just 2% of over-18s and 10% of under-18s in treatment 3 CLUB DRUGS: EMERGING TRENDS AND RISKS Slide 3

4 Slide 4 CLUB DRUGS: EMERGING TRENDS AND RISKS

5 Slide 5 CLUB DRUGS: EMERGING TRENDS AND RISKS

Characteristics:  Users different than those traditionally seen by services  Do not appear to be replacing more traditional drugs, such as heroin and crack  Can cause serious health problems and can lead to dependency  Use tends to be characterised by binge rather than regular use  Longer period between reported first use and presenting to treatment  Often prompted by acute health effect/episode  Club drug users do well in treatment. 6 Slide 6 CLUB DRUGS: EMERGING TRENDS AND RISKS

Characteristics:  Differ greatly from mainstream treatment population  Users typically have good personal resources  Often highly educated  Are employed  Are socially functional  Lack criminal convictions  Voluntarily engage with treatment  Have shorter treatment episodes  Club drug users do well in treatment. 7 Slide 7 CLUB DRUGS: EMERGING TRENDS AND RISKS

Findings:  8% report injecting Mephedrone (in last 2 years)  Users made up 4% of all new entrants to drug treatment in 2011/12 (2675/70,000) compared to 47,000 for Heroin/crack  Ecstasy remains the most common  Overall average age of treatment population increasing  43% of club drug users in the age range  70% of Mephedrone and 50% GBH/GBL aged over 30  U-18 Ecstasy presentations has fallen by 68% from  Last year, 61% of over-18 and 74% of under-18 club drugs users who left treatment did so successfully 8 Slide 8 CLUB DRUGS: EMERGING TRENDS AND RISKS

Conclusions:  Treatment numbers remain relatively small  Rates of IV use are minimal  No graduation to other substances  Enter treatment voluntarily  Users typically have good personal resources  Respond well to treatment  Treatment episodes tend to be relatively short  Services responsive and adaptive to changing trends  Range of substances is increasing  Continued investment is crucial 9 Slide 9 CLUB DRUGS: EMERGING TRENDS AND RISKS

10 CLUB DRUGS: EMERGING TRENDS AND RISKS  Full copy of the report available at: ads/clubdrugsreport2012[0 ].pdf ads/clubdrugsreport2012[0 ].pdf Slide 10